Mary Beth Fritz Sells 9,885 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) Stock

Prestige Consumer Healthcare Inc. (NYSE:PBH) SVP Mary Beth Fritz sold 9,885 shares of Prestige Consumer Healthcare stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $81.97, for a total transaction of $810,273.45. Following the transaction, the senior vice president now owns 18,835 shares in the company, valued at $1,543,904.95. The trade was a 34.42 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Prestige Consumer Healthcare Stock Performance

NYSE:PBH opened at $82.36 on Friday. The firm has a 50-day moving average of $73.13 and a two-hundred day moving average of $70.18. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.56 and a quick ratio of 2.10. The stock has a market cap of $4.07 billion, a P/E ratio of 20.04, a PEG ratio of 2.32 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a 1-year low of $56.61 and a 1-year high of $83.83.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, November 7th. The company reported $1.09 EPS for the quarter, meeting analysts’ consensus estimates of $1.09. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The firm had revenue of $283.79 million during the quarter, compared to the consensus estimate of $282.09 million. During the same quarter in the prior year, the business posted $1.07 earnings per share. Prestige Consumer Healthcare’s revenue for the quarter was down .9% on a year-over-year basis. On average, research analysts expect that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current fiscal year.

Institutional Trading of Prestige Consumer Healthcare

Hedge funds have recently made changes to their positions in the stock. Ariel Investments LLC lifted its position in shares of Prestige Consumer Healthcare by 10.7% during the second quarter. Ariel Investments LLC now owns 2,835,203 shares of the company’s stock worth $195,204,000 after purchasing an additional 274,212 shares during the last quarter. Victory Capital Management Inc. lifted its holdings in Prestige Consumer Healthcare by 9.0% during the 2nd quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company’s stock worth $142,827,000 after buying an additional 171,357 shares during the last quarter. Allspring Global Investments Holdings LLC grew its position in shares of Prestige Consumer Healthcare by 19.3% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,575,170 shares of the company’s stock worth $113,570,000 after acquiring an additional 255,045 shares in the last quarter. Congress Asset Management Co. increased its holdings in shares of Prestige Consumer Healthcare by 7.8% in the 3rd quarter. Congress Asset Management Co. now owns 865,123 shares of the company’s stock valued at $62,375,000 after acquiring an additional 62,411 shares during the last quarter. Finally, Boston Trust Walden Corp acquired a new stake in shares of Prestige Consumer Healthcare during the 3rd quarter valued at approximately $41,785,000. Institutional investors and hedge funds own 99.95% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on PBH shares. DA Davidson restated a “buy” rating and set a $95.00 price objective on shares of Prestige Consumer Healthcare in a research note on Monday, November 11th. Jefferies Financial Group reissued a “hold” rating and set a $76.00 price target (up from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. One research analyst has rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, Prestige Consumer Healthcare presently has an average rating of “Moderate Buy” and an average target price of $83.67.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.